Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortiumNatasha B Leighl, Scott A Laurie, Xueyu E Chen, et al.The Journal of Heredity|August 19, 2007
A cytogenetically characterized, genome-anchored 10-Mb BAC set and CGH array for the domestic dogRachael Thomas, Shannon E Duke, Stephanie K Bloom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.Nature Protocols|December 15, 2020
Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencingPeter Ellis, Luiza Moore, Mathijs A Sanders, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20Andrew M Arnold, Lesley Seymour, Michael Smylie, et al.Science (New York, N.Y.)|May 23, 2015
Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skinIñigo Martincorena, Amit Roshan, Moritz Gerstung, et al.Science (New York, N.Y.)|October 16, 2010
PiggyBac transposon mutagenesis: a tool for cancer gene discovery in miceRoland Rad, Lena Rad, Wei Wang, et al.Plos One|September 3, 2010
Complex exon-intron marking by histone modifications is not determined solely by nucleosome distributionPawandeep Dhami, Peter Saffrey, Alexander W Bruce, et al.Molecular Oncology|August 16, 2023
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1αOlga-Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, et al.Biological Reviews of the Cambridge Philosophical Society|February 22, 2021
Meiosis and beyond - understanding the mechanistic and evolutionary processes shaping the germline genomeRoberta Bergero, Peter Ellis, Wilfried Haerty, et al.Pageof 15